Please try another search
Balaxi Pharmaceuticals Limited is an India-based intellectual property research (IPR) pharmaceutical company. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It has a portfolio across multiple therapeutic segments, stock & sell models, and supplying branded and generic medicines. The Company is offerings more than 300 products across multiple therapeutic areas, including Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhoea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents and Laxative. Its consumer products include Nice 45 G, Guloso 45 G, Snax! 42 G, Doce E Sal 42 G, Yumm 75 G and Boadent.
Name | Age | Since | Title |
---|---|---|---|
Minoshi Maheshwari | 50 | 2017 | Non Executive Director |
Gandhi Gamji | 53 | 2017 | Independent Non-Executive Director |
Kunal Mahendra Bhakta | 40 | 2017 | Independent Non-Executive Director |
Ashish Maheshwari | - | 2017 | MD & Executive Chairman |
Purnima Singh Kamble | 50 | 2021 | Additional Independent Non-Executive Director |
M. Srinivas Rao | 63 | 2020 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review